nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—trigeminal nerve—germ cell cancer	0.123	0.257	CbGeAlD
Fosaprepitant—TACR1—vagus nerve—germ cell cancer	0.115	0.241	CbGeAlD
Fosaprepitant—TACR1—cranial nerve—germ cell cancer	0.0874	0.183	CbGeAlD
Fosaprepitant—TACR1—ganglion—germ cell cancer	0.0442	0.0928	CbGeAlD
Fosaprepitant—TACR1—brainstem—germ cell cancer	0.0192	0.0404	CbGeAlD
Fosaprepitant—TACR1—telencephalon—germ cell cancer	0.0171	0.0358	CbGeAlD
Fosaprepitant—TACR1—adrenal gland—germ cell cancer	0.0124	0.026	CbGeAlD
Fosaprepitant—TACR1—spinal cord—germ cell cancer	0.0119	0.0251	CbGeAlD
Fosaprepitant—TACR1—endocrine gland—germ cell cancer	0.0108	0.0226	CbGeAlD
Fosaprepitant—TACR1—head—germ cell cancer	0.0106	0.0223	CbGeAlD
Fosaprepitant—TACR1—testis—germ cell cancer	0.0103	0.0215	CbGeAlD
Fosaprepitant—TACR1—brain—germ cell cancer	0.0077	0.0162	CbGeAlD
Fosaprepitant—TACR1—lymph node—germ cell cancer	0.00744	0.0156	CbGeAlD
Fosaprepitant—Immune system disorder—Ifosfamide—germ cell cancer	0.00177	0.00337	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00176	0.00337	CcSEcCtD
Fosaprepitant—Cough—Bleomycin—germ cell cancer	0.00174	0.00332	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00172	0.00329	CcSEcCtD
Fosaprepitant—Infestation NOS—Etoposide—germ cell cancer	0.00172	0.00329	CcSEcCtD
Fosaprepitant—Infestation—Etoposide—germ cell cancer	0.00172	0.00329	CcSEcCtD
Fosaprepitant—Anaemia—Dactinomycin—germ cell cancer	0.00172	0.00328	CcSEcCtD
Fosaprepitant—Bradycardia—Cisplatin—germ cell cancer	0.00172	0.00328	CcSEcCtD
Fosaprepitant—Mental disorder—Ifosfamide—germ cell cancer	0.00171	0.00327	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00171	0.00326	CcSEcCtD
Fosaprepitant—Erythema—Ifosfamide—germ cell cancer	0.0017	0.00325	CcSEcCtD
Fosaprepitant—Malnutrition—Ifosfamide—germ cell cancer	0.0017	0.00325	CcSEcCtD
Fosaprepitant—Chest pain—Bleomycin—germ cell cancer	0.0017	0.00324	CcSEcCtD
Fosaprepitant—Stomatitis—Etoposide—germ cell cancer	0.00168	0.0032	CcSEcCtD
Fosaprepitant—Discomfort—Bleomycin—germ cell cancer	0.00168	0.0032	CcSEcCtD
Fosaprepitant—Malaise—Dactinomycin—germ cell cancer	0.00168	0.0032	CcSEcCtD
Fosaprepitant—Decreased appetite—Vinblastine—germ cell cancer	0.00167	0.0032	CcSEcCtD
Fosaprepitant—Urine output increased—Methotrexate—germ cell cancer	0.00167	0.00318	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Cisplatin—germ cell cancer	0.00167	0.00318	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Cisplatin—germ cell cancer	0.00166	0.00316	CcSEcCtD
Fosaprepitant—Urethral disorder—Cisplatin—germ cell cancer	0.00165	0.00316	CcSEcCtD
Fosaprepitant—Pain—Vinblastine—germ cell cancer	0.00165	0.00314	CcSEcCtD
Fosaprepitant—Constipation—Vinblastine—germ cell cancer	0.00165	0.00314	CcSEcCtD
Fosaprepitant—Oedema—Bleomycin—germ cell cancer	0.00163	0.00311	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Bleomycin—germ cell cancer	0.00163	0.00311	CcSEcCtD
Fosaprepitant—Infection—Bleomycin—germ cell cancer	0.00162	0.00309	CcSEcCtD
Fosaprepitant—Feeling abnormal—Vinblastine—germ cell cancer	0.00159	0.00303	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00158	0.00302	CcSEcCtD
Fosaprepitant—Eye disorder—Cisplatin—germ cell cancer	0.00158	0.00301	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00157	0.00301	CcSEcCtD
Fosaprepitant—Anaemia—Ifosfamide—germ cell cancer	0.00157	0.00301	CcSEcCtD
Fosaprepitant—Tinnitus—Cisplatin—germ cell cancer	0.00157	0.003	CcSEcCtD
Fosaprepitant—Flushing—Cisplatin—germ cell cancer	0.00157	0.00299	CcSEcCtD
Fosaprepitant—Cardiac disorder—Cisplatin—germ cell cancer	0.00157	0.00299	CcSEcCtD
Fosaprepitant—Discomfort—Dactinomycin—germ cell cancer	0.00156	0.00299	CcSEcCtD
Fosaprepitant—Angioedema—Ifosfamide—germ cell cancer	0.00156	0.00297	CcSEcCtD
Fosaprepitant—Thrombophlebitis—Methotrexate—germ cell cancer	0.00155	0.00295	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Etoposide—germ cell cancer	0.00154	0.00294	CcSEcCtD
Fosaprepitant—Malaise—Ifosfamide—germ cell cancer	0.00154	0.00293	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Etoposide—germ cell cancer	0.00153	0.00291	CcSEcCtD
Fosaprepitant—Immune system disorder—Cisplatin—germ cell cancer	0.00152	0.00291	CcSEcCtD
Fosaprepitant—Abdominal pain—Vinblastine—germ cell cancer	0.00152	0.00291	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Cisplatin—germ cell cancer	0.00152	0.0029	CcSEcCtD
Fosaprepitant—Hypotension—Bleomycin—germ cell cancer	0.00152	0.0029	CcSEcCtD
Fosaprepitant—Oedema—Dactinomycin—germ cell cancer	0.00152	0.0029	CcSEcCtD
Fosaprepitant—Urethral disorder—Etoposide—germ cell cancer	0.00151	0.00289	CcSEcCtD
Fosaprepitant—Infection—Dactinomycin—germ cell cancer	0.00151	0.00288	CcSEcCtD
Fosaprepitant—Palpitations—Ifosfamide—germ cell cancer	0.00151	0.00287	CcSEcCtD
Fosaprepitant—Cough—Ifosfamide—germ cell cancer	0.00149	0.00284	CcSEcCtD
Fosaprepitant—Hypertension—Ifosfamide—germ cell cancer	0.00147	0.00281	CcSEcCtD
Fosaprepitant—Malnutrition—Cisplatin—germ cell cancer	0.00147	0.0028	CcSEcCtD
Fosaprepitant—Erythema—Cisplatin—germ cell cancer	0.00147	0.0028	CcSEcCtD
Fosaprepitant—Erythema multiforme—Etoposide—germ cell cancer	0.00146	0.00279	CcSEcCtD
Fosaprepitant—Dyspnoea—Bleomycin—germ cell cancer	0.00145	0.00277	CcSEcCtD
Fosaprepitant—Chest pain—Ifosfamide—germ cell cancer	0.00145	0.00277	CcSEcCtD
Fosaprepitant—Flatulence—Cisplatin—germ cell cancer	0.00145	0.00276	CcSEcCtD
Fosaprepitant—Eye disorder—Etoposide—germ cell cancer	0.00144	0.00276	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00144	0.00275	CcSEcCtD
Fosaprepitant—Cardiac disorder—Etoposide—germ cell cancer	0.00143	0.00274	CcSEcCtD
Fosaprepitant—Flushing—Etoposide—germ cell cancer	0.00143	0.00274	CcSEcCtD
Fosaprepitant—Discomfort—Ifosfamide—germ cell cancer	0.00143	0.00274	CcSEcCtD
Fosaprepitant—Hypersensitivity—Vinblastine—germ cell cancer	0.00142	0.00271	CcSEcCtD
Fosaprepitant—Decreased appetite—Bleomycin—germ cell cancer	0.00141	0.0027	CcSEcCtD
Fosaprepitant—Muscle spasms—Cisplatin—germ cell cancer	0.00141	0.0027	CcSEcCtD
Fosaprepitant—Angiopathy—Etoposide—germ cell cancer	0.0014	0.00268	CcSEcCtD
Fosaprepitant—Immune system disorder—Etoposide—germ cell cancer	0.0014	0.00266	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Etoposide—germ cell cancer	0.00139	0.00266	CcSEcCtD
Fosaprepitant—Pain—Bleomycin—germ cell cancer	0.00139	0.00266	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00139	0.00265	CcSEcCtD
Fosaprepitant—Oedema—Ifosfamide—germ cell cancer	0.00139	0.00265	CcSEcCtD
Fosaprepitant—Asthenia—Vinblastine—germ cell cancer	0.00138	0.00264	CcSEcCtD
Fosaprepitant—Infection—Ifosfamide—germ cell cancer	0.00138	0.00264	CcSEcCtD
Fosaprepitant—Lethargy—Methotrexate—germ cell cancer	0.00137	0.00261	CcSEcCtD
Fosaprepitant—Nervous system disorder—Ifosfamide—germ cell cancer	0.00136	0.0026	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Cisplatin—germ cell cancer	0.00136	0.0026	CcSEcCtD
Fosaprepitant—Anaemia—Cisplatin—germ cell cancer	0.00136	0.00259	CcSEcCtD
Fosaprepitant—Skin disorder—Ifosfamide—germ cell cancer	0.00135	0.00258	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00134	0.00257	CcSEcCtD
Fosaprepitant—Feeling abnormal—Bleomycin—germ cell cancer	0.00134	0.00256	CcSEcCtD
Fosaprepitant—Osteoarthritis—Methotrexate—germ cell cancer	0.00134	0.00255	CcSEcCtD
Fosaprepitant—Malaise—Cisplatin—germ cell cancer	0.00132	0.00253	CcSEcCtD
Fosaprepitant—Decreased appetite—Dactinomycin—germ cell cancer	0.00132	0.00252	CcSEcCtD
Fosaprepitant—Diarrhoea—Vinblastine—germ cell cancer	0.00132	0.00252	CcSEcCtD
Fosaprepitant—Dysgeusia—Etoposide—germ cell cancer	0.00132	0.00252	CcSEcCtD
Fosaprepitant—Fatigue—Dactinomycin—germ cell cancer	0.00131	0.0025	CcSEcCtD
Fosaprepitant—Hypotension—Ifosfamide—germ cell cancer	0.0013	0.00248	CcSEcCtD
Fosaprepitant—Pain—Dactinomycin—germ cell cancer	0.0013	0.00248	CcSEcCtD
Fosaprepitant—Muscle spasms—Etoposide—germ cell cancer	0.00129	0.00247	CcSEcCtD
Fosaprepitant—Urticaria—Bleomycin—germ cell cancer	0.00129	0.00247	CcSEcCtD
Fosaprepitant—Body temperature increased—Bleomycin—germ cell cancer	0.00129	0.00245	CcSEcCtD
Fosaprepitant—Dizziness—Vinblastine—germ cell cancer	0.00127	0.00243	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dactinomycin—germ cell cancer	0.00125	0.00239	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Etoposide—germ cell cancer	0.00125	0.00238	CcSEcCtD
Fosaprepitant—Anxiety—Cisplatin—germ cell cancer	0.00125	0.00238	CcSEcCtD
Fosaprepitant—Anaemia—Etoposide—germ cell cancer	0.00124	0.00237	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00124	0.00237	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00124	0.00237	CcSEcCtD
Fosaprepitant—Dyspnoea—Ifosfamide—germ cell cancer	0.00124	0.00237	CcSEcCtD
Fosaprepitant—Somnolence—Ifosfamide—germ cell cancer	0.00124	0.00236	CcSEcCtD
Fosaprepitant—Discomfort—Cisplatin—germ cell cancer	0.00124	0.00236	CcSEcCtD
Fosaprepitant—Vomiting—Vinblastine—germ cell cancer	0.00122	0.00234	CcSEcCtD
Fosaprepitant—Malaise—Etoposide—germ cell cancer	0.00121	0.00232	CcSEcCtD
Fosaprepitant—Decreased appetite—Ifosfamide—germ cell cancer	0.00121	0.00231	CcSEcCtD
Fosaprepitant—Headache—Vinblastine—germ cell cancer	0.00121	0.0023	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0012	0.0023	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Abdominal pain—Dactinomycin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Body temperature increased—Dactinomycin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Fatigue—Ifosfamide—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Oedema—Cisplatin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Cisplatin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Hypersensitivity—Bleomycin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Fosaprepitant—Infection—Cisplatin—germ cell cancer	0.00119	0.00227	CcSEcCtD
Fosaprepitant—Constipation—Ifosfamide—germ cell cancer	0.00119	0.00227	CcSEcCtD
Fosaprepitant—Pain—Ifosfamide—germ cell cancer	0.00119	0.00227	CcSEcCtD
Fosaprepitant—Loss of consciousness—Etoposide—germ cell cancer	0.00118	0.00226	CcSEcCtD
Fosaprepitant—Nervous system disorder—Cisplatin—germ cell cancer	0.00118	0.00224	CcSEcCtD
Fosaprepitant—Cough—Etoposide—germ cell cancer	0.00117	0.00224	CcSEcCtD
Fosaprepitant—Asthenia—Bleomycin—germ cell cancer	0.00117	0.00223	CcSEcCtD
Fosaprepitant—Skin disorder—Cisplatin—germ cell cancer	0.00116	0.00222	CcSEcCtD
Fosaprepitant—Hypertension—Etoposide—germ cell cancer	0.00116	0.00222	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Cisplatin—germ cell cancer	0.00116	0.00221	CcSEcCtD
Fosaprepitant—Pruritus—Bleomycin—germ cell cancer	0.00115	0.0022	CcSEcCtD
Fosaprepitant—Feeling abnormal—Ifosfamide—germ cell cancer	0.00115	0.00219	CcSEcCtD
Fosaprepitant—Chest pain—Etoposide—germ cell cancer	0.00115	0.00219	CcSEcCtD
Fosaprepitant—Nausea—Vinblastine—germ cell cancer	0.00114	0.00218	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00114	0.00217	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00114	0.00217	CcSEcCtD
Fosaprepitant—Discomfort—Etoposide—germ cell cancer	0.00113	0.00216	CcSEcCtD
Fosaprepitant—Hypotension—Cisplatin—germ cell cancer	0.00112	0.00214	CcSEcCtD
Fosaprepitant—Hypersensitivity—Dactinomycin—germ cell cancer	0.00112	0.00213	CcSEcCtD
Fosaprepitant—Abdominal discomfort—Methotrexate—germ cell cancer	0.00111	0.00212	CcSEcCtD
Fosaprepitant—Urticaria—Ifosfamide—germ cell cancer	0.0011	0.00211	CcSEcCtD
Fosaprepitant—Body temperature increased—Ifosfamide—germ cell cancer	0.0011	0.0021	CcSEcCtD
Fosaprepitant—Abdominal pain—Ifosfamide—germ cell cancer	0.0011	0.0021	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Etoposide—germ cell cancer	0.0011	0.0021	CcSEcCtD
Fosaprepitant—Infection—Etoposide—germ cell cancer	0.00109	0.00208	CcSEcCtD
Fosaprepitant—Asthenia—Dactinomycin—germ cell cancer	0.00109	0.00208	CcSEcCtD
Fosaprepitant—Dysuria—Methotrexate—germ cell cancer	0.00108	0.00206	CcSEcCtD
Fosaprepitant—Dyspnoea—Cisplatin—germ cell cancer	0.00107	0.00204	CcSEcCtD
Fosaprepitant—Skin disorder—Etoposide—germ cell cancer	0.00107	0.00204	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Etoposide—germ cell cancer	0.00106	0.00203	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00106	0.00202	CcSEcCtD
Fosaprepitant—Decreased appetite—Cisplatin—germ cell cancer	0.00104	0.00199	CcSEcCtD
Fosaprepitant—Diarrhoea—Dactinomycin—germ cell cancer	0.00104	0.00198	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00103	0.00198	CcSEcCtD
Fosaprepitant—Vomiting—Bleomycin—germ cell cancer	0.00103	0.00197	CcSEcCtD
Fosaprepitant—Infestation NOS—Methotrexate—germ cell cancer	0.00103	0.00197	CcSEcCtD
Fosaprepitant—Infestation—Methotrexate—germ cell cancer	0.00103	0.00197	CcSEcCtD
Fosaprepitant—Hypotension—Etoposide—germ cell cancer	0.00103	0.00196	CcSEcCtD
Fosaprepitant—Rash—Bleomycin—germ cell cancer	0.00103	0.00196	CcSEcCtD
Fosaprepitant—Pain—Cisplatin—germ cell cancer	0.00102	0.00196	CcSEcCtD
Fosaprepitant—Dermatitis—Bleomycin—germ cell cancer	0.00102	0.00196	CcSEcCtD
Fosaprepitant—Hypersensitivity—Ifosfamide—germ cell cancer	0.00102	0.00196	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00102	0.00195	CcSEcCtD
Fosaprepitant—Stomatitis—Methotrexate—germ cell cancer	0.00101	0.00192	CcSEcCtD
Fosaprepitant—Conjunctivitis—Methotrexate—germ cell cancer	0.001	0.00191	CcSEcCtD
Fosaprepitant—Asthenia—Ifosfamide—germ cell cancer	0.000997	0.0019	CcSEcCtD
Fosaprepitant—Feeling abnormal—Cisplatin—germ cell cancer	0.000988	0.00189	CcSEcCtD
Fosaprepitant—Pruritus—Ifosfamide—germ cell cancer	0.000983	0.00188	CcSEcCtD
Fosaprepitant—Haematuria—Methotrexate—germ cell cancer	0.000983	0.00188	CcSEcCtD
Fosaprepitant—Dyspnoea—Etoposide—germ cell cancer	0.000979	0.00187	CcSEcCtD
Fosaprepitant—Somnolence—Etoposide—germ cell cancer	0.000976	0.00186	CcSEcCtD
Fosaprepitant—Nausea—Bleomycin—germ cell cancer	0.000966	0.00184	CcSEcCtD
Fosaprepitant—Vomiting—Dactinomycin—germ cell cancer	0.000965	0.00184	CcSEcCtD
Fosaprepitant—Rash—Dactinomycin—germ cell cancer	0.000956	0.00183	CcSEcCtD
Fosaprepitant—Decreased appetite—Etoposide—germ cell cancer	0.000954	0.00182	CcSEcCtD
Fosaprepitant—Diarrhoea—Ifosfamide—germ cell cancer	0.000951	0.00182	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000948	0.00181	CcSEcCtD
Fosaprepitant—Body temperature increased—Cisplatin—germ cell cancer	0.000947	0.00181	CcSEcCtD
Fosaprepitant—Fatigue—Etoposide—germ cell cancer	0.000947	0.00181	CcSEcCtD
Fosaprepitant—Pain—Etoposide—germ cell cancer	0.000939	0.00179	CcSEcCtD
Fosaprepitant—Constipation—Etoposide—germ cell cancer	0.000939	0.00179	CcSEcCtD
Fosaprepitant—Dizziness—Ifosfamide—germ cell cancer	0.000919	0.00176	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Methotrexate—germ cell cancer	0.000914	0.00175	CcSEcCtD
Fosaprepitant—Urethral disorder—Methotrexate—germ cell cancer	0.000907	0.00173	CcSEcCtD
Fosaprepitant—Feeling abnormal—Etoposide—germ cell cancer	0.000905	0.00173	CcSEcCtD
Fosaprepitant—Nausea—Dactinomycin—germ cell cancer	0.000901	0.00172	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Etoposide—germ cell cancer	0.000898	0.00171	CcSEcCtD
Fosaprepitant—Vomiting—Ifosfamide—germ cell cancer	0.000884	0.00169	CcSEcCtD
Fosaprepitant—Hypersensitivity—Cisplatin—germ cell cancer	0.000883	0.00169	CcSEcCtD
Fosaprepitant—Rash—Ifosfamide—germ cell cancer	0.000876	0.00167	CcSEcCtD
Fosaprepitant—Dermatitis—Ifosfamide—germ cell cancer	0.000876	0.00167	CcSEcCtD
Fosaprepitant—Erythema multiforme—Methotrexate—germ cell cancer	0.000875	0.00167	CcSEcCtD
Fosaprepitant—Urticaria—Etoposide—germ cell cancer	0.000872	0.00167	CcSEcCtD
Fosaprepitant—Abdominal pain—Etoposide—germ cell cancer	0.000868	0.00166	CcSEcCtD
Fosaprepitant—Body temperature increased—Etoposide—germ cell cancer	0.000868	0.00166	CcSEcCtD
Fosaprepitant—Eye disorder—Methotrexate—germ cell cancer	0.000865	0.00165	CcSEcCtD
Fosaprepitant—Tinnitus—Methotrexate—germ cell cancer	0.000863	0.00165	CcSEcCtD
Fosaprepitant—Asthenia—Cisplatin—germ cell cancer	0.00086	0.00164	CcSEcCtD
Fosaprepitant—Cardiac disorder—Methotrexate—germ cell cancer	0.000859	0.00164	CcSEcCtD
Fosaprepitant—Angiopathy—Methotrexate—germ cell cancer	0.00084	0.0016	CcSEcCtD
Fosaprepitant—Immune system disorder—Methotrexate—germ cell cancer	0.000836	0.0016	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Methotrexate—germ cell cancer	0.000834	0.00159	CcSEcCtD
Fosaprepitant—Nausea—Ifosfamide—germ cell cancer	0.000826	0.00158	CcSEcCtD
Fosaprepitant—Diarrhoea—Cisplatin—germ cell cancer	0.00082	0.00157	CcSEcCtD
Fosaprepitant—Mental disorder—Methotrexate—germ cell cancer	0.000811	0.00155	CcSEcCtD
Fosaprepitant—Hypersensitivity—Etoposide—germ cell cancer	0.000809	0.00154	CcSEcCtD
Fosaprepitant—Erythema—Methotrexate—germ cell cancer	0.000806	0.00154	CcSEcCtD
Fosaprepitant—Malnutrition—Methotrexate—germ cell cancer	0.000806	0.00154	CcSEcCtD
Fosaprepitant—Dysgeusia—Methotrexate—germ cell cancer	0.000789	0.00151	CcSEcCtD
Fosaprepitant—Asthenia—Etoposide—germ cell cancer	0.000788	0.0015	CcSEcCtD
Fosaprepitant—Pruritus—Etoposide—germ cell cancer	0.000777	0.00148	CcSEcCtD
Fosaprepitant—Vomiting—Cisplatin—germ cell cancer	0.000762	0.00145	CcSEcCtD
Fosaprepitant—Rash—Cisplatin—germ cell cancer	0.000756	0.00144	CcSEcCtD
Fosaprepitant—Dermatitis—Cisplatin—germ cell cancer	0.000755	0.00144	CcSEcCtD
Fosaprepitant—Diarrhoea—Etoposide—germ cell cancer	0.000751	0.00143	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Methotrexate—germ cell cancer	0.000748	0.00143	CcSEcCtD
Fosaprepitant—Anaemia—Methotrexate—germ cell cancer	0.000745	0.00142	CcSEcCtD
Fosaprepitant—Malaise—Methotrexate—germ cell cancer	0.000727	0.00139	CcSEcCtD
Fosaprepitant—Dizziness—Etoposide—germ cell cancer	0.000726	0.00139	CcSEcCtD
Fosaprepitant—Nausea—Cisplatin—germ cell cancer	0.000712	0.00136	CcSEcCtD
Fosaprepitant—Cough—Methotrexate—germ cell cancer	0.000703	0.00134	CcSEcCtD
Fosaprepitant—Vomiting—Etoposide—germ cell cancer	0.000698	0.00133	CcSEcCtD
Fosaprepitant—Rash—Etoposide—germ cell cancer	0.000692	0.00132	CcSEcCtD
Fosaprepitant—Dermatitis—Etoposide—germ cell cancer	0.000692	0.00132	CcSEcCtD
Fosaprepitant—Headache—Etoposide—germ cell cancer	0.000688	0.00131	CcSEcCtD
Fosaprepitant—Chest pain—Methotrexate—germ cell cancer	0.000686	0.00131	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000681	0.0013	CcSEcCtD
Fosaprepitant—Discomfort—Methotrexate—germ cell cancer	0.000678	0.00129	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methotrexate—germ cell cancer	0.000658	0.00126	CcSEcCtD
Fosaprepitant—Infection—Methotrexate—germ cell cancer	0.000653	0.00125	CcSEcCtD
Fosaprepitant—Nausea—Etoposide—germ cell cancer	0.000652	0.00125	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methotrexate—germ cell cancer	0.000645	0.00123	CcSEcCtD
Fosaprepitant—Skin disorder—Methotrexate—germ cell cancer	0.000639	0.00122	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methotrexate—germ cell cancer	0.000636	0.00121	CcSEcCtD
Fosaprepitant—Hypotension—Methotrexate—germ cell cancer	0.000615	0.00117	CcSEcCtD
Fosaprepitant—Insomnia—Methotrexate—germ cell cancer	0.000595	0.00114	CcSEcCtD
Fosaprepitant—Dyspnoea—Methotrexate—germ cell cancer	0.000586	0.00112	CcSEcCtD
Fosaprepitant—Somnolence—Methotrexate—germ cell cancer	0.000585	0.00112	CcSEcCtD
Fosaprepitant—Dyspepsia—Methotrexate—germ cell cancer	0.000579	0.00111	CcSEcCtD
Fosaprepitant—Decreased appetite—Methotrexate—germ cell cancer	0.000572	0.00109	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000568	0.00108	CcSEcCtD
Fosaprepitant—Fatigue—Methotrexate—germ cell cancer	0.000567	0.00108	CcSEcCtD
Fosaprepitant—Pain—Methotrexate—germ cell cancer	0.000562	0.00107	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methotrexate—germ cell cancer	0.000542	0.00103	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000538	0.00103	CcSEcCtD
Fosaprepitant—Urticaria—Methotrexate—germ cell cancer	0.000522	0.000997	CcSEcCtD
Fosaprepitant—Body temperature increased—Methotrexate—germ cell cancer	0.00052	0.000993	CcSEcCtD
Fosaprepitant—Abdominal pain—Methotrexate—germ cell cancer	0.00052	0.000993	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methotrexate—germ cell cancer	0.000485	0.000925	CcSEcCtD
Fosaprepitant—Asthenia—Methotrexate—germ cell cancer	0.000472	0.000901	CcSEcCtD
Fosaprepitant—Pruritus—Methotrexate—germ cell cancer	0.000465	0.000888	CcSEcCtD
Fosaprepitant—Diarrhoea—Methotrexate—germ cell cancer	0.00045	0.000859	CcSEcCtD
Fosaprepitant—Dizziness—Methotrexate—germ cell cancer	0.000435	0.00083	CcSEcCtD
Fosaprepitant—Vomiting—Methotrexate—germ cell cancer	0.000418	0.000798	CcSEcCtD
Fosaprepitant—Rash—Methotrexate—germ cell cancer	0.000415	0.000792	CcSEcCtD
Fosaprepitant—Dermatitis—Methotrexate—germ cell cancer	0.000414	0.000791	CcSEcCtD
Fosaprepitant—Headache—Methotrexate—germ cell cancer	0.000412	0.000787	CcSEcCtD
Fosaprepitant—Nausea—Methotrexate—germ cell cancer	0.000391	0.000746	CcSEcCtD
